Overview

Low-Dose Aspirin in in Vitro Fertilization (IVF) and Intracytoplasmic Sperm Injection (ICSI) Treatments

Status:
Completed
Trial end date:
2006-03-01
Target enrollment:
Participant gender:
Summary
In this study we hypothesized that low-dose aspirin therapy (100 mg daily) improves ovarian responsiveness, uterine haemodynamics and clinical pregnancy rates in unselected subjects undergoing IVF/ICSI when the treatment is started concomitantly with controlled ovarian hyperstimulation.
Phase:
N/A
Details
Lead Sponsor:
University of Oulu
Collaborators:
Bayer
Kuopio University Hospital
Tampere University
University of Tampere
Treatments:
Aspirin